What imaging is required for a patient with progressive loss of smell and metallic taste?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Imaging for Progressive Loss of Smell and Metallic Taste

MRI of the orbits, face, and neck is the recommended imaging modality for patients with progressive loss of smell and metallic taste when clinical evaluation warrants imaging. 1

When Is Imaging Required?

Most patients with olfactory symptoms do not require imaging unless history or physical examination findings warrant it. The diagnostic approach should follow this algorithm:

  1. Initial clinical evaluation:

    • Nasal endoscopy to rule out structural abnormalities or inflammatory conditions
    • Objective smell testing using validated tests (UPSIT or Sniffin' Sticks)
  2. Imaging indications (when to proceed with imaging):

    • Progressive symptoms without obvious cause on endoscopy
    • Unilateral symptoms
    • Associated neurological symptoms
    • No improvement with initial treatment
    • Suspicion of sinonasal or skull base tumors
    • History of trauma

Imaging Modality Selection

First-line imaging:

  • MRI orbits, face, and neck with contrast: Best for directly visualizing the olfactory apparatus and associated structures 1
    • Provides optimal assessment of the olfactory bulbs, tracts, and brain structures
    • Can detect tumors affecting the cribriform plate (squamous cell carcinomas, meningiomas, esthesioneuroblastomas)
    • Can identify inflammatory lesions (sarcoidosis, granulomatosis with polyangiitis)
    • Can evaluate for neurodegenerative disorders associated with olfactory dysfunction

Alternative/complementary imaging:

  • CT Maxillofacial: Useful for evaluating 1, 2:
    • Sinonasal inflammatory disease
    • Bony anatomy affecting olfaction
    • Fractures (in cases with trauma history)
    • Rhinosinusitis with nasal polyposis

Imaging Protocol Considerations

  • MRI protocols should cover the major anatomic divisions of the olfactory pathway 1:

    • Olfactory epithelium (upper nasal cavity)
    • Olfactory neurons and bulbs (cribriform plate and inferior frontal lobes)
    • Olfactory pathways (portions of temporal and frontal lobes)
  • Thin-cut high-resolution techniques should be employed for optimal visualization 1

  • Pre- and post-contrast MRI provides the best opportunity to identify and characterize lesions 1

Common Pitfalls to Avoid

  1. Inadequate imaging protocols: Standard brain MRI may not adequately evaluate the olfactory apparatus; specific protocols are needed 2

  2. Misattribution of symptoms: Patients often confuse smell and taste disorders; 95% of taste disorders are actually caused by impairment of smell 3

  3. Overlooking subtle findings: Small lesions affecting the olfactory pathway can be missed without proper imaging techniques

  4. Unnecessary imaging: Studies have shown low diagnostic yield in patients with isolated anosmia and normal endoscopy 4, so imaging should be reserved for cases with concerning features

Clinical Context

The etiology of olfactory dysfunction falls into three main categories 1, 2:

  1. Conduction loss: Sinonasal passage obstruction
  2. Sensorineural loss: Olfactory neuroepithelial damage
  3. Central nervous system disorders: Affecting olfactory processing

Common causes include:

  • Inflammatory sinonasal disorders
  • Upper respiratory infections (including COVID-19)
  • Trauma
  • Tumors affecting the cribriform plate
  • Neurodegenerative disorders (Parkinson's, Alzheimer's)
  • Congenital conditions

The metallic taste component may represent a qualitative disturbance (dysosmia) or could be related to taste dysfunction mediated through other cranial nerves, which further supports the need for comprehensive imaging when clinically indicated.

By following this evidence-based approach to imaging selection, clinicians can appropriately evaluate patients with progressive loss of smell and metallic taste while avoiding unnecessary testing.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Post-Traumatic Olfactory Dysfunction Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Smell and taste disorders in primary care.

American family physician, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.